
A pediatric dermatologist explains how to read itch, sleep, and quality-of-life findings from phase 2 nemolizumab data in children aged 2 - 11.
In this slideshow, we highlight four atopic dermatitis phenotypes in children as described in JAMA Pediatrics.
(©SkylinesShutterstock.com)
See the related story,






